Cover Image
Market Research Report
Product code 
1034490

Clot Management Devices (Cardiovascular Devices) - Medical Devices Pipeline Product Landscape, 2021

Published: | GlobalData | 91 Pages | Delivery time: 1-2 business days

Price

Back to Top
Clot Management Devices (Cardiovascular Devices) - Medical Devices Pipeline Product Landscape, 2021
Published: October 29, 2021
GlobalData
Content info: 91 Pages
Delivery time: 1-2 business days
  • Description
  • Table of Contents
  • List of Tables

GlobalData's Medical Devices sector report, "Clot Management Devices (Cardiovascular Devices) - Medical Devices Pipeline Product Landscape, 2021" provides comprehensive information about the Clot Management Devices pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

Clot Management Devices are used for the removal or dissolution of a clot from a blood vessel to restore proper blood circulation. This device is used as a routine procedure while performing Percutaneous Coronary Intervention and to treat potentially life-threatening complications such as deep vein thrombosis (DVT) and pulmonary embolism (PE).

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

  • Extensive coverage of the Clot Management Devices under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Clot Management Devices and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry

Reasons to Buy

The report enables you to -

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage
  • Identify and understand important and diverse types of Clot Management Devices under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product's current stage of development, territory and estimated launch date
Product Code: GDME1169EPD

Table of Contents

1 Table of Contents

  • 1.1 List of Tables
  • 1.2 List of Figures

2 Introduction

  • 2.1 Clot Management Devices Overview

3 Products under Development

  • 3.1 Clot Management Devices - Pipeline Products by Stage of Development
  • 3.2 Clot Management Devices - Pipeline Products by Segment
  • 3.3 Clot Management Devices - Pipeline Products by Territory
  • 3.4 Clot Management Devices - Pipeline Products by Regulatory Path
  • 3.5 Clot Management Devices - Pipeline Products by Estimated Approval Date
  • 3.6 Clot Management Devices - Ongoing Clinical Trials

4 Clot Management Devices - Pipeline Products under Development by Companies

  • 4.1 Clot Management Devices Companies - Pipeline Products by Stage of Development
  • 4.2 Clot Management Devices - Pipeline Products by Stage of Development

5 Clot Management Devices Companies and Product Overview

  • 5.1 Adient Medical Inc. Company Overview
    • 5.1.1 Adient Medical Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.2 AngioDynamics Inc Company Overview
    • 5.2.1 AngioDynamics Inc Pipeline Products & Ongoing Clinical Trials Overview
  • 5.3 AorticLab Sarl Company Overview
    • 5.3.1 AorticLab Sarl Pipeline Products & Ongoing Clinical Trials Overview
  • 5.4 APT Medical Inc Company Overview
    • 5.4.1 APT Medical Inc Pipeline Products & Ongoing Clinical Trials Overview
  • 5.5 Boston Scientific Corp Company Overview
    • 5.5.1 Boston Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview
  • 5.6 Caeli Vascular LLC Company Overview
    • 5.6.1 Caeli Vascular LLC Pipeline Products & Ongoing Clinical Trials Overview
  • 5.7 Capture Vascular Inc Company Overview
    • 5.7.1 Capture Vascular Inc Pipeline Products & Ongoing Clinical Trials Overview
  • 5.8 Contego Medical LLC Company Overview
    • 5.8.1 Contego Medical LLC Pipeline Products & Ongoing Clinical Trials Overview
  • 5.9 CyndRX LLC Company Overview
    • 5.9.1 CyndRX LLC Pipeline Products & Ongoing Clinical Trials Overview
  • 5.10 Inari Medical Inc Company Overview
    • 5.10.1 Inari Medical Inc Pipeline Products & Ongoing Clinical Trials Overview
  • 5.11 Interventional & Surgical Innovations, LLC Company Overview
    • 5.11.1 Interventional & Surgical Innovations, LLC Pipeline Products & Ongoing Clinical Trials Overview
  • 5.12 Kaleidoscope Company Overview
    • 5.12.1 Kaleidoscope Pipeline Products & Ongoing Clinical Trials Overview
  • 5.13 Koninklijke Philips NV Company Overview
    • 5.13.1 Koninklijke Philips NV Pipeline Products & Ongoing Clinical Trials Overview
  • 5.14 Lazarus Effect, Inc Company Overview
    • 5.14.1 Lazarus Effect, Inc Pipeline Products & Ongoing Clinical Trials Overview
  • 5.15 LeMaitre Vascular Inc Company Overview
    • 5.15.1 LeMaitre Vascular Inc Pipeline Products & Ongoing Clinical Trials Overview
  • 5.16 Lithotech Medical Ltd Company Overview
    • 5.16.1 Lithotech Medical Ltd Pipeline Products & Ongoing Clinical Trials Overview
  • 5.17 Merit Medical Systems Inc Company Overview
    • 5.17.1 Merit Medical Systems Inc Pipeline Products & Ongoing Clinical Trials Overview
  • 5.18 MicroPort Endovascular (Shanghai) Co., Ltd. Company Overview
    • 5.18.1 MicroPort Endovascular (Shanghai) Co., Ltd. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.19 NexGen Medical Systems Inc Company Overview
    • 5.19.1 NexGen Medical Systems Inc Pipeline Products & Ongoing Clinical Trials Overview
  • 5.20 OsciFlex LLC Company Overview
    • 5.20.1 OsciFlex LLC Pipeline Products & Ongoing Clinical Trials Overview
  • 5.21 Penumbra Inc Company Overview
    • 5.21.1 Penumbra Inc Pipeline Products & Ongoing Clinical Trials Overview
  • 5.22 Shenzhen Salubris Pharmaceuticals Co Ltd Company Overview
    • 5.22.1 Shenzhen Salubris Pharmaceuticals Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
  • 5.23 Shenzhen Tengfu Medical Technology Co Ltd Company Overview
    • 5.23.1 Shenzhen Tengfu Medical Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
  • 5.24 Suzhou Tianhong Shengjie Medical Co Ltd Company Overview
    • 5.24.1 Suzhou Tianhong Shengjie Medical Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
  • 5.25 TransMed7 LLC Company Overview
    • 5.25.1 TransMed7 LLC Pipeline Products & Ongoing Clinical Trials Overview
  • 5.26 University of Arizona Company Overview
    • 5.26.1 University of Arizona Pipeline Products & Ongoing Clinical Trials Overview
  • 5.27 University of California Los Angeles Company Overview
    • 5.27.1 University of California Los Angeles Pipeline Products & Ongoing Clinical Trials Overview
  • 5.28 University of Michigan Company Overview
    • 5.28.1 University of Michigan Pipeline Products & Ongoing Clinical Trials Overview
  • 5.29 University of Toledo Company Overview
    • 5.29.1 University of Toledo Pipeline Products & Ongoing Clinical Trials Overview
  • 5.30 University of Wolverhampton Company Overview
    • 5.30.1 University of Wolverhampton Pipeline Products & Ongoing Clinical Trials Overview
  • 5.31 Veniti Inc Company Overview
    • 5.31.1 Veniti Inc Pipeline Products & Ongoing Clinical Trials Overview
  • 5.32 Vetex Medical Ltd Company Overview
    • 5.32.1 Vetex Medical Ltd Pipeline Products & Ongoing Clinical Trials Overview
  • 5.33 VueKlar Cardiovascular Ltd (Inactive) Company Overview
    • 5.33.1 VueKlar Cardiovascular Ltd (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
  • 5.34 WaveClear Inc Company Overview
    • 5.34.1 WaveClear Inc Pipeline Products & Ongoing Clinical Trials Overview
  • 5.35 Zylox-Tonbridge Medical Technology Co Ltd Company Overview
    • 5.35.1 Zylox-Tonbridge Medical Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview

6 Clot Management Devices- Recent Developments

  • 6.1 Sep 09, 2021: Boston Scientific Announces 2021 Investor Day Meeting
  • 6.2 Jun 30, 2021: B. Braun Announces Jennifer Prioleau as New Chief Legal Officer and Chief Compliance Officer
  • 6.3 May 24, 2021: Boston Scientific to Participate in Bernstein's 37th Annual Strategic Decisions Conference
  • 6.4 Feb 17, 2021: Medtronic Executives to Speak at Upcoming Investor Conferences
  • 6.5 Feb 16, 2021: Medtronic to Announce Financial Results for Its Third Quarter of Fiscal Year 2021
  • 6.6 Feb 12, 2021: Boston Scientific Announces February and March 2021 Conference Schedule
  • 6.7 Dec 28, 2020: Cook Medical launches a new Customer Portal to enhance customer experience

7 Appendix

  • 7.1 Methodology
  • 7.2 About GlobalData
  • 7.3 Contact Us
  • 7.4 Disclaimer

List of Tables

List of Tables

  • Clot Management Devices - Pipeline Products by Stage of Development
  • Clot Management Devices - Pipeline Products by Segment
  • Clot Management Devices - Pipeline Products by Territory
  • Clot Management Devices - Pipeline Products by Regulatory Path
  • Clot Management Devices - Pipeline Products by Estimated Approval Date
  • Clot Management Devices - Ongoing Clinical Trials
  • Clot Management Devices Companies - Pipeline Products by Stage of Development
  • Clot Management Devices - Pipeline Products by Stage of Development
  • Glossary

List of Figures

List of Figures

  • Clot Management Devices - Pipeline Products by Stage of Development
  • Clot Management Devices - Pipeline Products by Segment
  • Clot Management Devices - Pipeline Products by Territory
  • Clot Management Devices - Pipeline Products by Regulatory Path
  • Clot Management Devices - Pipeline Products by Estimated Approval Date
  • Clot Management Devices - Ongoing Clinical Trials